Doogan Declan

SEC Form 4 insider trading activity

Doogan Declan has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.

On the most recent filing, Doogan Declan is listed as Director at TENAX THERAPEUTICS, INC. Inside the rolling window, Doogan Declan reported 1 open-market purchase totaling $102K in TENX and no open-market sales.

Companies traded

Other insiders at TENX

Insider Buying

$102K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TENX
Doogan Declan
Purchase$102KSep 18SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Doogan Declan made?

Doogan Declan has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Doogan Declan trade?

Doogan Declan has filed SEC Form 4 disclosures for 1 company, including TENX.

When was Doogan Declan's most recent SEC Form 4 filing?

Doogan Declan's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.

What is Doogan Declan's total buy and sell value in the current window?

Inside the rolling retention window, Doogan Declan bought $102K and sold $0 based on SEC Form 4 filings.

What was Doogan Declan's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 53,000 TENX shares on 2026-09-16, worth $102K, per SEC Form 4 filings.